Skip to Content


Active Substance: mangafodipir trisodium
Common Name: mangafodipir
ATC Code: V08CA05
Marketing Authorisation Holder: GE Healthcare AS
Active Substance: mangafodipir trisodium
Status: Withdrawn
Authorisation Date: 1997-05-22
Therapeutic Area: Magnetic Resonance Imaging
Pharmacotherapeutic Group: Contrast media

Therapeutic Indication

This medicinal product is for diagnostic use only.

Contrast medium for diagnostic magnetic resonance imaging (MRI) for the detection of lesions of the liver suspected to be due to metastatic disease or hepatocellular carcinomas. As an adjunct to MRI to aid in the investigation of focal pancreatic lesions.

The marketing authorisation for Teslascan has been withdrawn at the request of the marketing-authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.